Health

Results: 3169-3180 of 4058

Sectra leads the market in PACS considerations and selections

Imlifidase demonstrated positive safety, tolerability, and early efficacy outcomes in 15-HMedIdeS-09 phase 2 trial in Guillain-Barré Syndrome (GBS)

PR Newswire associated0

Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS

LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches

PR Newswire associated0

Micro Medical Solutions Announces Completion of Enrollment in the STAND Pivotal Clinical Trial

Merck Collaborates with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation Planner

Rizwan Velji has joined Alentis Therapeutics as Chief Business Officer (Photo: Alentis Therapeutics)

Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer

PR Newswire associated0

SaniSure earns EcoVadis Silver Rating, recognizing strong commitment to sustainability

Velocity Clinical Research expands to Poland

PR Newswire associated0

GreenAwareness launches pop-up to encourage single-use vape recycling

Stent before expansion (Photo: Business Wire)

Kaneka Acquires Japan Medical Device Technology

Business Wire logo

New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity